PhaseBio Pharmaceuticals, Inc.

Organization

Malverm, PA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for treating muscle disease and disorders
- Patent number 11,266,719
- Issue date Mar 8, 2022
- Phasebio Pharmaceuticals, Inc.
- Lynne Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metalloenzyme inhibitor compounds
- Patent number 11,136,309
- Issue date Oct 5, 2021
- Phasebio Pharmaceuticals, Inc.
- Steven Sparks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for treating cystic fibrosis
- Patent number 11,052,132
- Issue date Jul 6, 2021
- Phasebio Pharmaceuticals, Inc.
- Susan Arnold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metalloenzyme inhibitor compounds
- Patent number 11,040,034
- Issue date Jun 22, 2021
- Phasebio Pharmaceuticals, Inc.
- Steven Sparks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of modified vasoactive intestinal peptides in the treatment of...
- Patent number 10,940,182
- Issue date Mar 9, 2021
- Phasebio Pharmaceuticals, Inc.
- Lynne M. Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ELP fusion proteins for controlled and sustained release
- Patent number 10,722,590
- Issue date Jul 28, 2020
- Phasebio Pharmaceuticals, Inc.
- James Jowett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treating muscle disease and disorders
- Patent number 10,688,156
- Issue date Jun 23, 2020
- Phasebio Pharmaceuticals, Inc.
- Lynne Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for administering a sustained release formulation
- Patent number 9,919,032
- Issue date Mar 20, 2018
- Phasebio Pharmaceuticals, Inc.
- Susan Arnold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified vasoactive intestinal peptides
- Patent number 9,700,598
- Issue date Jul 11, 2017
- Phasebio Pharmaceuticals, Inc.
- Homayoun Sadeghi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of modified vasoactive intestinal peptides in the treatment of...
- Patent number 9,561,262
- Issue date Feb 7, 2017
- Phasebio Pharmaceuticals, Inc.
- Lynne M. Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified vasoactive intestinal peptides
- Patent number 9,029,505
- Issue date May 12, 2015
- Phasebio Pharmaceuticals, Inc.
- Homayoun Sadeghi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multimeric ELP fusion constructs
- Patent number 7,709,227
- Issue date May 4, 2010
- PhaseBio Pharmaceuticals, Inc.
- Suzanne Dagher
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PHARMACOKINETIC & PHARMACODYNAMIC MODEL FOR DETERMINING EFFECTIVE D...
- Publication number 20230192895
- Publication date Jun 22, 2023
- PhaseBio Pharmaceuticals, Inc.
- John LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VASOACTIVE INTESTINAL PEPTIDE FUSION PROTEINS FOR THE TREATMENT OF...
- Publication number 20230173030
- Publication date Jun 8, 2023
- PhaseBio Pharmaceuticals, Inc.
- John LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
- Publication number 20220288170
- Publication date Sep 15, 2022
- PhaseBio Pharmaceuticals, Inc.
- Lynne GEORGOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ELP FUSION PROTEINS COMPRISING PARATHYROID HORMONE FOR CONTROLLED A...
- Publication number 20220289812
- Publication date Sep 15, 2022
- PhaseBio Pharmaceuticals, Inc.
- David James BALLANCE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
- Publication number 20220023390
- Publication date Jan 27, 2022
- PhaseBio Pharmaceuticals, Inc.
- Susan ARNOLD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METALLOENZYME INHIBITOR COMPOUNDS
- Publication number 20220009907
- Publication date Jan 13, 2022
- PhaseBio Pharmaceuticals, Inc.
- Steven Sparks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF REVERSING TICAGRELOR ACTIVITY
- Publication number 20210347915
- Publication date Nov 11, 2021
- PhaseBio Pharmaceuticals, Inc.
- John LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METALLOENZYME INHIBITOR COMPOUNDS
- Publication number 20210322409
- Publication date Oct 21, 2021
- PhaseBio Pharmaceuticals, Inc.
- Steven SPARKS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
- Publication number 20210069299
- Publication date Mar 11, 2021
- PhaseBio Pharmaceuticals, Inc.
- Lynne GEORGOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METALLOENZYME INHIBITOR COMPOUNDS
- Publication number 20200392112
- Publication date Dec 17, 2020
- PhaseBio Pharmaceuticals, Inc.
- Steven Sparks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
- Publication number 20200353091
- Publication date Nov 12, 2020
- PhaseBio Pharmaceuticals, Inc.
- James JOWETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
- Publication number 20190218274
- Publication date Jul 18, 2019
- PhaseBio Pharmaceuticals, Inc.
- James JOWETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
- Publication number 20190015523
- Publication date Jan 17, 2019
- PhaseBio Pharmaceuticals, Inc.
- James JOWETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
- Publication number 20180333467
- Publication date Nov 22, 2018
- PhaseBio Pharmaceuticals, Inc.
- Lynne GEORGOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED VASOACTIVE INTESTINAL PEPTIDES
- Publication number 20180008677
- Publication date Jan 11, 2018
- PhaseBio Pharmaceuticals, Inc.
- Homayoun Sadeghi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
- Publication number 20170182130
- Publication date Jun 29, 2017
- PhaseBio Pharmaceuticals, Inc.
- Susan ARNOLD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
- Publication number 20170136092
- Publication date May 18, 2017
- PhaseBio Pharmaceuticals, Inc.
- Susan Arnold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF...
- Publication number 20170072021
- Publication date Mar 16, 2017
- PhaseBio Pharmaceuticals, Inc.
- Lynne M. Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED VASOACTIVE INTESTINAL PEPTIDES
- Publication number 20160220642
- Publication date Aug 4, 2016
- PhaseBio Pharmaceuticals, Inc.
- Homayoun Sadeghi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS, COMPOSITIONS, AND METHODS FOR GLYCEMIC CONTROL
- Publication number 20150361154
- Publication date Dec 17, 2015
- PHASEBIO PHARMACEUTICALS, INC.
- James JOWETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
- Publication number 20150290328
- Publication date Oct 15, 2015
- PHASEBIO PHARMACEUTICALS, INC.
- Susan Arnold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND TREATMENT WITH GLP-1 RECEPTOR AGONISTS
- Publication number 20150111816
- Publication date Apr 23, 2015
- PhaseBio Pharmaceuticals, Inc.
- Lynne M. GEORGOPOULOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF...
- Publication number 20150111829
- Publication date Apr 23, 2015
- PhaseBio Pharmaceuticals, Inc.
- Lynne M. Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
- Publication number 20140171370
- Publication date Jun 19, 2014
- PhaseBio Pharmaceuticals, Inc.
- Susan Arnold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
- Publication number 20130178416
- Publication date Jul 11, 2013
- PhaseBio Pharmaceuticals, Inc.
- Ashutosh Chilkoti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC AGENTS COMPRISING INSULIN AMINO ACID SEQUENCES
- Publication number 20130150291
- Publication date Jun 13, 2013
- PhaseBio Pharmaceuticals, Inc.
- James Jowett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
- Publication number 20130143802
- Publication date Jun 6, 2013
- PhaseBio Pharmaceuticals, Inc.
- Ashutosh Chilkoti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATMENT WITH GLP-1 RECEPTOR AGONISTS
- Publication number 20130090285
- Publication date Apr 11, 2013
- PhaseBio Pharmaceuticals, Inc.
- Lynne M. Georgopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
- Publication number 20130084277
- Publication date Apr 4, 2013
- PhaseBio Pharmaceuticals, Inc.
- Susan Arnold
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED VASOACTIVE INTESTINAL PEPTIDES
- Publication number 20110178017
- Publication date Jul 21, 2011
- PhaseBio Pharmaceuticals, Inc.
- Homayoun Sadeghi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90808332 - RETRIG
- Serial number 90808332
- Filing date Jul 2, 2021
- PhaseBio Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90808336 - OPMIZTA
- Serial number 90808336
- Filing date Jul 2, 2021
- PhaseBio Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90808334 - XYFT
- Serial number 90808334
- Filing date Jul 2, 2021
- PhaseBio Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88847647 - PB PHASEBIO
- Serial number 88847647
- Filing date Mar 25, 2020
- PhaseBio Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88107576 - PHASEBIO
- Serial number 88107576
- Registration number 7037266
- Filing date Sep 6, 2018
- PhaseBio Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85489562 - INSUMERA
- Serial number 85489562
- Filing date Dec 7, 2011
- PhaseBio Pharmaceuticals
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85192220 - OXYMERA
- Serial number 85192220
- Filing date Dec 7, 2010
- PhaseBio Pharmaceuticals Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85188043 - VASOMERA
- Serial number 85188043
- Filing date Dec 1, 2010
- PhaseBio Pharmaceuticals Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85187306 - GLYMERA
- Serial number 85187306
- Filing date Nov 30, 2010
- PhaseBio Pharmaceuticals
- 5 - Pharmaceutical and veterinary preparations

PhaseBio Pharmaceuticals, Inc.

Organization

Patents Grantslast 30 patents

Methods and compositions for treating muscle disease and disorders

Metalloenzyme inhibitor compounds

Methods and compositions for treating cystic fibrosis

Metalloenzyme inhibitor compounds

Use of modified vasoactive intestinal peptides in the treatment of...

ELP fusion proteins for controlled and sustained release

Methods and compositions for treating muscle disease and disorders

Method for administering a sustained release formulation

Modified vasoactive intestinal peptides

Use of modified vasoactive intestinal peptides in the treatment of...

Modified vasoactive intestinal peptides

Multimeric ELP fusion constructs

Patents Applicationslast 30 patents

PHARMACOKINETIC & PHARMACODYNAMIC MODEL FOR DETERMINING EFFECTIVE D...

VASOACTIVE INTESTINAL PEPTIDE FUSION PROTEINS FOR THE TREATMENT OF...

METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

ELP FUSION PROTEINS COMPRISING PARATHYROID HORMONE FOR CONTROLLED A...

METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

METALLOENZYME INHIBITOR COMPOUNDS

METHODS OF REVERSING TICAGRELOR ACTIVITY

METALLOENZYME INHIBITOR COMPOUNDS

METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

METALLOENZYME INHIBITOR COMPOUNDS

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

MODIFIED VASOACTIVE INTESTINAL PEPTIDES

METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF...

MODIFIED VASOACTIVE INTESTINAL PEPTIDES

THERAPEUTIC AGENTS, COMPOSITIONS, AND METHODS FOR GLYCEMIC CONTROL

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

METHODS AND TREATMENT WITH GLP-1 RECEPTOR AGONISTS

USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF...

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

THERAPEUTIC AGENTS COMPRISING INSULIN AMINO ACID SEQUENCES

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

METHODS OF TREATMENT WITH GLP-1 RECEPTOR AGONISTS

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Trademarklast 30 trademarks

90808332 - RETRIG

90808336 - OPMIZTA

90808334 - XYFT

88847647 - PB PHASEBIO

88107576 - PHASEBIO

85489562 - INSUMERA

85192220 - OXYMERA

85188043 - VASOMERA

85187306 - GLYMERA